BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1341 related articles for article (PubMed ID: 12816671)

  • 1. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
    Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
    Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus typing in HIV-positive women.
    Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
    Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection in women infected with the human immunodeficiency virus.
    Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
    N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
    Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.
    Naud P; Matos J; Hammes L; Stuckzynski J; Brouwers K; Magno V; Dias E; Crusius P; d'Avila A; Campos C; Costa M; Höblik M; Marc C; Marroni R; Syrjänen K
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):110-8. PubMed ID: 16386655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
    Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
    J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study.
    Sun CA; Hsiung CA; Lai CH; Chen CA; Chou CY; Ho CM; Twu NF; Feng WL; Chuang MH; Hsieh CY; Chu TY
    J Med Virol; 2005 Oct; 77(2):273-81. PubMed ID: 16121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
    Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
    J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus genotypes in women from three clinical settings.
    Chaturvedi AK; Dumestre J; Gaffga AM; Mire KM; Clark RA; Braly PS; Dunlap K; Beckel TE; Hammons AF; Kissinger PJ; Hagensee ME
    J Med Virol; 2005 Jan; 75(1):105-13. PubMed ID: 15543579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.